Rhythm Pharmaceuticals (RYTM) Net Cash Flow (QoQ) (2017 - 2026)
Rhythm Pharmaceuticals (RYTM) Net Cash Flow (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rhythm Pharmaceuticals | 6.98 Bn | 6.64 Bn | 52.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 271.49% |
| Dec 31, 2025 | 102.40% |
| Sep 30, 2025 | -380.45% |
| Jun 30, 2025 | 75.90% |
| Mar 31, 2025 | -58.27% |
| Dec 31, 2024 | 135.79% |
| Sep 30, 2024 | -204.61% |
| Jun 30, 2024 | 1,782.81% |
| Mar 31, 2024 | -49.31% |
| Dec 31, 2023 | 91.56% |
| Sep 30, 2023 | -933.90% |
| Jun 30, 2023 | 133.90% |
| Mar 31, 2023 | 68.47% |
| Dec 31, 2022 | -179.87% |
| Sep 30, 2022 | 107.33% |
| Jun 30, 2022 | 79.74% |
| Mar 31, 2022 | 158.23% |
| Dec 31, 2021 | -243.81% |
| Sep 30, 2021 | 228.45% |
| Jun 30, 2021 | -31.29% |